Medtronic Provision for Credit Losses decreased by 5.3% to $36.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 29.4%, from $51.00M to $36.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase suggests deteriorating credit quality or portfolio growth, while a decrease may indicate improved borrower health or more conservative lending.
This is an expense set aside to cover expected future losses on loans and credit card receivables. It reflects managemen...
Standard for all lenders and credit card issuers.
is_provision_for_credit_losses| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $15.00M | $19.00M | $15.00M | $15.00M | $26.00M | $13.00M | $21.00M | $16.00M | $25.00M | $18.00M | $27.00M | $51.00M | $28.00M | $38.00M | $36.00M |
| QoQ Change | — | +26.7% | -21.1% | +0.0% | +73.3% | -50.0% | +61.5% | -23.8% | +56.3% | -28.0% | +50.0% | +88.9% | -45.1% | +35.7% | -5.3% |
| YoY Change | — | — | — | +0.0% | +36.8% | -13.3% | +40.0% | -38.5% | +92.3% | -14.3% | +68.8% | +104.0% | +55.6% | +40.7% | -29.4% |